Podcasts about Eli Lilly

Cramer says this pharmaceutical giant is ‘so far ahead' of its peers in drug trials. This episode contains a preview of exclusive content from the members-only CNBC Investing Club morning meeting. Become an Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks every day as they talk candidly about the market's biggest headlines, analyst calls and holdings in the Charitable Trust – and see up close how they decide when, and if, to take action on stocks. Sign up here: cnbc.com/morningtake CNBC Investing Club Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Another day of early software stock declines:Carl Quintanilla, Jim Cramer and David Faber broke down the biggest moves - and names Jim thinks are worth buying the dip for. Chips in focus after a wide-ranging interview with Nvidia CEO Jensen Huang on Mad Money overnight - who shot down rumors of strain in their OpenAI partnership - along with AMD earnings... Hear AMD CEO Lisa Su herself breakdown the numbers and where she sees growth ahead.  Plus: the team also discussed how to trade some of the morning's biggest earnings reports - from Chipotle to Eli Lilly to Uber.  Squawk on the Street Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

The US is ramping up efforts to secure its supplies of critical minerals. Vice-president JD Vance has proposed creating a new critical mineral trading bloc to loosen China's control over the sector. The approach could reshape global supply chains for materials essential to electric vehicles, semiconductors and defence systems. Ed Butler finds out more. Shares of Ozempic manufacturer, Novo Nordisk, dropped as nuch as 17% in the face of strong competition. Meanwhile its rival Eli Lilly, is forecasting strong growth. What's the outlook for weight-loss jabs? Elsewhere, the US has renewed an agreement that gives 32 African countries access to the US market. The African Growth and Opportunity Act was allowed to expire last September, after 25 years. It's now been re-authorised until the end of 2026, although Washington has warned it may reshape the deal after that.

Send us a textThis week on On The Pen: The Weekly Dose, Dave breaks down one of the most consequential Eli Lilly earnings calls to date. We dive into major updates on retatrutide, new Phase 3 timelines, and why Lilly is positioning next-generation GLP-1 and GIP therapies far beyond obesity, including osteoarthritis, sleep apnea, addiction, and mental health. From manufacturing scale and Medicare access to brand-new molecules like bernipotide and amylin-based therapies, this episode explores what the future of incretin medicine could really look like for patients.Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!

This week on Market Mondays, we break down the Investing Fact of the Week and answer the Trading Question of the Week, tackling some of the most asked questions in the market right now. We discuss whether this is the right time to buy Oracle, if gold and silver have finished falling, and share our end-of-year price target for Palantir. We also give a clear Bitcoin outlook, analyze what's next for Eli Lilly, and explain how the new Fed Chair could impact stocks, interest rates, and the broader economy.To close the episode, we dive into one of the most important investor questions: when to take profits without sabotaging long-term wealth. Plus, we sit down with Mikey Taylor to discuss entrepreneurship, private equity, financial freedom, and the role of investing in local communities. This episode is packed with actionable insights for both long-term investors and active traders looking to stay ahead of the market.Invest Fest Tickets: investfest.com#MarketMondays #Investing #StockMarket #Trading #Bitcoin #Crypto #OracleStock #Palantir #Gold #Silver #EliLilly #FedPolicy #InterestRates #TakingProfits #FinancialFreedom #PrivateEquity #Entrepreneurship #WealthBuilding #LongTermInvesting #PassiveIncomeSupport this podcast at — https://redcircle.com/marketmondays/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Send us a textThis week on On The Pen: The Weekly Dose, we break down Pfizer's $10 billion bet on obesity medicine and whether it's shaping up to be a smart move or a costly miss. We dig into newly released Phase 2b data from Pfizer's once-monthly GLP-1 candidate (formerly Metsera's asset), what the results actually show, and how it stacks up in an increasingly crowded field that includes Novo Nordisk, Eli Lilly, and next-gen combination therapies. We also talk strategy, maintenance dosing, combination GLP-1 + amylin approaches, pricing pressures, cash-pay access, and what this all means for patients navigating a rapidly changing obesity treatment landscape. Plus, earnings week insights, where Pfizer may be headed next, and why pricing and access, not just weight-loss percentages, may end up being the real disruptors.Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!

很多生技人常感嘆：為什麼我們的技術明明領先，估值卻比不上競爭對手？或者是臨床數據這麼好，為什麼股價不漲反跌？生技業界最神祕的，可能不一定是實驗室裡的獨家配方，而是辦公大樓裡分析師手中的那套財務模型和投資邏輯。我們習慣用專業技術去解讀公司前景，卻經常忽略資本市場如何將『科學可能性』轉換成『商業價值』。 本集《生技來一刻》特別邀請前 J.P. Morgan 分析師 Vincent，從宏觀的生技業界總覽出發，帶我們回溯中國大陸生技業的發展簡史，並探索台灣生技在亞洲與全球資本市場中的可以尋求的定位。與此同時我們也針對當前最火紅的 GLP-1 減重藥市場巨頭（Eli Lilly vs. Novo Nordisk）以及數位醫療商業模式（Teladoc vs. HIMS & Hers）進行了極其硬核的個案分析。這不僅是藥物研發的對抗，更是商業模式與市場滲透策略的頂尖對決。 除了扎實的產業分析，這場訪談更觸及了投資背後的靈魂——決策的藝術。Vincent 將他多年在資本市場修煉的「下注與風險控制」心法，轉化為人人都適用的思考框架。我們深入探討了波動稅務 (volatility tax)的意義和對人生決策的啟發、如何辨識 Type 1 與 Type 2 錯誤、第一印象的重要性、以及通才和專才發展的平衡，讓大家在充滿不確定性的人生賽道上，做出最有價值的選擇。   ✨ 生技來一刻感謝國科會與駐波士頓辦事處科技組贊助我們製作節目。我們也歡迎聽眾小額捐款生技來一刻，您的支持能幫助我們製作更優質的節目。 ✨ 節目連結、講者Linkedin連結請見留言處！感謝講者提供詳盡的延伸閱讀連結和文章！  

GLP-1 drugs like Ozempic and Wegovy are everywhere — but thousands of users now allege the medications caused severe, life-altering injuries including everything from stomach paralysis and colon ruptures to sudden blindness. Drugmakers deny the allegations and say the medications are safe when used as directed. USA TODAY investigative data reporter Austin Fast explains what patients are alleging in court, how widespread GLP-1 use has become and how drug companies like Novo Nordisk and Eli Lilly are responding. Let us know what you think of this episode by sending an email to podcasts@usatoday.com. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Matt the Care Bair. Trump working to primary Rhino Hoosiers. Today’s Popcorn Moment: AG Todd Rokita talks about MN ICE, Eli Lilly, and Indiana Unclaimed. Today on the Marketplace: Plastic Coke Cups. Rep. Ilhan Omar Says All This Chaos Is About Rigging Elections, Not Immigration or FraudSee omnystudio.com/listener for privacy information.

Trump adds tariffs on South Korea because they have not yet approved the deal. Homan in, Bovino out….of Minneapolis. Trump speaks with Walz and Frey. Now residents can begin complaining about streets not being plowed. Every Holocaust comparison should be met with fierce pushback. Matt the Care Bair. Trump working to primary Rhino Hoosiers. Today’s Popcorn Moment: AG Todd Rokita talks about MN ICE, Eli Lilly, and Indiana Unclaimed. Today on the Marketplace: Plastic Coke Cups. Rep. Ilhan Omar Says All This Chaos Is About Rigging Elections, Not Immigration or Fraud. Wienie 500 returns. 100% tariffs on Canada if they make trade deal with China. Price of Gold and silver continue to go up. TV Theme Song: Rifleman See omnystudio.com/listener for privacy information.

In this episode, Bethanie Stein, PharmD, Segment President of Pharmacy at Humana, discusses how employers are approaching GLP-1 coverage and why partnerships with manufacturers like Eli Lilly and Novo Nordisk matter now. She shares how CenterWell Pharmacy is using transparency, clinical oversight, and adherence focused models to expand access while managing costs.

Think you know the story of AI's rise and fall? This episode upends conventional wisdom with guest historian Thomas Haigh, who reveals why the infamous "AI winter" might just be a myth and why the field's biggest failures fueled today's breakthroughs. Two Thinking Machines Lab Cofounders Are Leaving to Rejoin OpenAI NVDA, GOOGL, META: AI Spending Forecast to Hit $2.53 Trillion This Year Nvidia, Eli Lilly just say yes to making drugs together, using Vera Rubin GPUs Claude Cowork Exfiltrates Files We put Claude Code in Rollercoaster Tycoon How Generative AI is destroying society - by Gary Marcus Anthropic rewrites Claude's guiding principles—and entertains the idea that its AI might have 'some kind of consciousness or moral status' Claude's new constitution Hosts: Leo Laporte, Jeff Jarvis, and Paris Martineau Guest: Thomas Haigh Download or subscribe to Intelligent Machines at https://twit.tv/shows/intelligent-machines. Join Club TWiT for Ad-Free Podcasts! Support what you love and get ad-free audio and video feeds, a members-only Discord, and exclusive content. Join today: https://twit.tv/clubtwit Sponsors: bitwarden.com/twit monarch.com with code IM

Think you know the story of AI's rise and fall? This episode upends conventional wisdom with guest historian Thomas Haigh, who reveals why the infamous "AI winter" might just be a myth and why the field's biggest failures fueled today's breakthroughs. Two Thinking Machines Lab Cofounders Are Leaving to Rejoin OpenAI NVDA, GOOGL, META: AI Spending Forecast to Hit $2.53 Trillion This Year Nvidia, Eli Lilly just say yes to making drugs together, using Vera Rubin GPUs Claude Cowork Exfiltrates Files We put Claude Code in Rollercoaster Tycoon How Generative AI is destroying society - by Gary Marcus Anthropic rewrites Claude's guiding principles—and entertains the idea that its AI might have 'some kind of consciousness or moral status' Claude's new constitution Hosts: Leo Laporte, Jeff Jarvis, and Paris Martineau Guest: Thomas Haigh Download or subscribe to Intelligent Machines at https://twit.tv/shows/intelligent-machines. Join Club TWiT for Ad-Free Podcasts! Support what you love and get ad-free audio and video feeds, a members-only Discord, and exclusive content. Join today: https://twit.tv/clubtwit Sponsors: bitwarden.com/twit monarch.com with code IM

Think you know the story of AI's rise and fall? This episode upends conventional wisdom with guest historian Thomas Haigh, who reveals why the infamous "AI winter" might just be a myth and why the field's biggest failures fueled today's breakthroughs. Two Thinking Machines Lab Cofounders Are Leaving to Rejoin OpenAI NVDA, GOOGL, META: AI Spending Forecast to Hit $2.53 Trillion This Year Nvidia, Eli Lilly just say yes to making drugs together, using Vera Rubin GPUs Claude Cowork Exfiltrates Files We put Claude Code in Rollercoaster Tycoon How Generative AI is destroying society - by Gary Marcus Anthropic rewrites Claude's guiding principles—and entertains the idea that its AI might have 'some kind of consciousness or moral status' Claude's new constitution Hosts: Leo Laporte, Jeff Jarvis, and Paris Martineau Guest: Thomas Haigh Download or subscribe to Intelligent Machines at https://twit.tv/shows/intelligent-machines. Join Club TWiT for Ad-Free Podcasts! Support what you love and get ad-free audio and video feeds, a members-only Discord, and exclusive content. Join today: https://twit.tv/clubtwit Sponsors: bitwarden.com/twit monarch.com with code IM

Think you know the story of AI's rise and fall? This episode upends conventional wisdom with guest historian Thomas Haigh, who reveals why the infamous "AI winter" might just be a myth and why the field's biggest failures fueled today's breakthroughs. Two Thinking Machines Lab Cofounders Are Leaving to Rejoin OpenAI NVDA, GOOGL, META: AI Spending Forecast to Hit $2.53 Trillion This Year Nvidia, Eli Lilly just say yes to making drugs together, using Vera Rubin GPUs Claude Cowork Exfiltrates Files We put Claude Code in Rollercoaster Tycoon How Generative AI is destroying society - by Gary Marcus Anthropic rewrites Claude's guiding principles—and entertains the idea that its AI might have 'some kind of consciousness or moral status' Claude's new constitution Hosts: Leo Laporte, Jeff Jarvis, and Paris Martineau Guest: Thomas Haigh Download or subscribe to Intelligent Machines at https://twit.tv/shows/intelligent-machines. Join Club TWiT for Ad-Free Podcasts! Support what you love and get ad-free audio and video feeds, a members-only Discord, and exclusive content. Join today: https://twit.tv/clubtwit Sponsors: bitwarden.com/twit monarch.com with code IM

Think you know the story of AI's rise and fall? This episode upends conventional wisdom with guest historian Thomas Haigh, who reveals why the infamous "AI winter" might just be a myth and why the field's biggest failures fueled today's breakthroughs. Two Thinking Machines Lab Cofounders Are Leaving to Rejoin OpenAI NVDA, GOOGL, META: AI Spending Forecast to Hit $2.53 Trillion This Year Nvidia, Eli Lilly just say yes to making drugs together, using Vera Rubin GPUs Claude Cowork Exfiltrates Files We put Claude Code in Rollercoaster Tycoon How Generative AI is destroying society - by Gary Marcus Anthropic rewrites Claude's guiding principles—and entertains the idea that its AI might have 'some kind of consciousness or moral status' Claude's new constitution Hosts: Leo Laporte, Jeff Jarvis, and Paris Martineau Guest: Thomas Haigh Download or subscribe to Intelligent Machines at https://twit.tv/shows/intelligent-machines. Join Club TWiT for Ad-Free Podcasts! Support what you love and get ad-free audio and video feeds, a members-only Discord, and exclusive content. Join today: https://twit.tv/clubtwit Sponsors: bitwarden.com/twit monarch.com with code IM

In der heutigen Folge sprechen die Finanzjournalisten Anja Ettel und Philipp Vetter über Donald Trumps Auftritt in Davos, Zoff bei Lululemon, Optimismus bei US-Airlines und neue Nukelar-Euphorie. Außerdem geht es um United Airlines, Delta Airlines, American Airlines, Johnson&Johnson, Kraft Heinz, Berkshire Hathaway, NuScale Power, Nano Nuclear Energy, Oklo, enCore Energy, Uranium Energy, Nvidia, Siemens, ABB, Schneider Electric, Siemens Energy, Legrand, Prysmian, Safran, Rolls-Royce, Rheinmetall, NextEra Energy, Union Pacific, Enbridge, Duke Energy, SAP, Mastercard, Visa, Bank of America, Lockheed Martin, Boeing, Pfizer, Merck, Eli Lilly, iShares Stoxx Europe 600 Industrials ETF (WKN: A0H08J), L&G Robotics and Automation ETF (WKN: A12DB1) und iShares Global Infrastructure ETF (WKN: A0LEW9). Wir freuen uns an Feedback über aaa@welt.de. Noch mehr "Alles auf Aktien" findet Ihr bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter. Hier bei WELT: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html. Der Börsen-Podcast Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte! https://linktr.ee/alles_auf_aktien Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

In this episode of Beyond Rockets, host Clark Dunn sits down with Anusha Davis, Vice President of Retail at Crunkleton Commercial, for an in-depth look at the evolution of Huntsville's retail and mixed-use real estate landscape.Born and raised in Huntsville, Anusha shares her unconventional path into commercial real estate, starting with a background in communications and journalism before finding her footing in development and brokerage. She discusses what it's like to work on both sides of the table as a broker and former small business owner, and how that experience shapes the way she advocates for local entrepreneurs.The conversation dives into Huntsville's explosive post-2020 growth, major mixed-use projects like Stadium Commons and Front Row, and why national retailers are now prioritizing Huntsville over traditional markets like Birmingham. Anusha also breaks down retail vacancy rates, what major announcements like Mazda Toyota and Eli Lilly mean for the city, and which submarkets to watch heading into 2026.From North Parkway and South Huntsville to Lincoln Mill, Five Points, and beyond, this episode offers a behind-the-scenes look at how Huntsville is being thoughtfully planned, brokered, and built for the future.https://www.linkedin.com/in/anushaalapati/https://www.crunkletonassociates.com

The Food and Drug Administration on recently approved a pill version of Wegovy, Novo Nordisk's blockbuster weight loss drug. The Wegovy pill, as it's called, is first oral version of a GLP-1 drug that has been brought to market for weight loss. A second pill, from Eli Lilly, is also expected to be approved in the coming months. Nicolette M. Pace, a Registered Dietician, Chef, & Nutritionist, is here to talk about all this and more!

Welp. That was wild.

Soukaina Alaoui El Hassani (she/her) is a Moroccan‑born filmmaker and commercial producer based in New York, known for her clarity in storytelling and ability to lead creative teams through complex, high‑profile campaigns. Now a producer at Versus Creative Studio, she works across editorial, OOH, 2D animation, and CG — partnering with leading brands such as Boehringer Ingelheim, Eli Lilly and Company, MSG, Verizon, Paramount, Audible, Netflix, and more. Her sharp creative instincts, emotional intelligence, and ability to “pivot with confidence” allow her to approach production as both an art and a discipline, balancing storytelling and logistics with empathy and precision. Soukaina's mission spans commercial and independent film work: she's dedicated to championing authentic, underrepresented stories — offering new perspectives on identity, culture, and human experience. She is committed to mentorship, healthy team dynamics, and creating space for voices too often overlooked. In 2025 she was honoured as a Top Woman in Media and awarded the Creative Catalyst distinction by Cynopsis, recognizing the energy, leadership, and creative vision she brings to every collaboration.saelhassani.com

In der heutigen Folge sprechen die Finanzjournalisten Anja Ettel und Philipp Vetter über neue Hoffnung bei Novo Nordisk, Quanten-Angst beim Bitcoin und einen Erfolg für Bayer. Außerdem geht es um Micron, Worthington Steel, Klöckner & Co., Eli Lilly, Viking Therapeutics, Meta, Alphabet, Microsoft, Amazon, BMW, Maersk, Legrand, Nvidia, Tesla, den iShares MSCI World Energy Sector (WKN: A2PHCF), den Xtrackers MSCI World Energy (WKN: A113FF), den VanEck Uranium and Nuclear Technologies (WKN: A3D47K), den Xtrackers FTSE Vietnam Swap ETF (WKN: DBX1AG) und den VanEck Vietnam ETF (WKN: A2AHKE). Wir freuen uns an Feedback über aaa@welt.de. Noch mehr "Alles auf Aktien" findet Ihr bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter. Hier bei WELT: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html. Der Börsen-Podcast Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte! https://linktr.ee/alles_auf_aktien Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Market update for January 16, 2026Follow us on Instagram (@TheRundownDaily) for bonus content and instant reactions.In Today's Episode:Zaid quoted in the WSJ: “he just has aura”Eli Lilly and Novo Nordisk hit with antitrust lawsuitNetflix expands its Sony Pictures deal and pushes further into video podcastsEnergy stocks slide after the White House unveils a plan to stop power bills from going upFun fact of the day: Wall Street banks posted a record $134 billion in trading revenue (while still cutting thousands of jobs)

January 15, 2025: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: Gallup survey finds 29% of Americans say healthcare cost is the nation's most urgent health problem, with 23% calling the U.S. system "in a state of crisis" Fullscript and Oura partner to integrate smart ring data into clinical workflows for 125,000 providers, turning wearables into everyday decision-making tools NVIDIA and Eli Lilly announce AI innovation lab with plans to invest up to $1B over five years to reinvent drug discovery and manufacturing Nike signs pro pickleballer Anna Leigh Waters as its first pickleball partnership, targeting growth at the intersection of lifestyle, performance, and community More from Fitt: Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital. Subscribe to our newsletter → insider.fitt.co/subscribe Work with our recruiting firm → https://talent.fitt.co/ Follow us on Instagram → https://www.instagram.com/fittinsider/ Follow us on LinkedIn → linkedin.com/company/fittinsider Reach out → insider@fitt.co

Carl Quintanilla, Jim Cramer and David Faber discussed the Justice Department's criminal probe into Federal Reserve Chair Jerome Powell — and how it's facing blowback from both sides of the aisle on Capitol Hill, as well as condemnation from central bankers around the globe. The anchors also discussed JPMorgan Chase's quarterly beat as the bank's results kick off earnings season. In a CNBC Exclusive at the J.P. Morgan Healthcare Conference in San Francisco, Jim interviewed Eli Lilly CEO David Ricks about obesity drugs and the company's growth into a $1 trillion pharma giant. Also in focus: December CPI holds steady at 2.7% year-on-year, Microsoft's new data center initiative to lower power costs. Squawk on the Street Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Market update for January 13, 2026Follow us on Instagram (@TheRundownDaily) for bonus content and instant reactions.In today's episode:• Google crosses $4 trillion after Apple taps Gemini to power Siri• CPI comes in as expected, with inflation holding steady at 2.7%• What the latest inflation data means for the Fed and rate cuts• JPMorgan kicks off earnings season with a big trading-driven beat• Nvidia and Eli Lilly announce a $1B partnership to use AI in drug discovery• Market movers: Intel and AMD rally, Delta slides after earnings

Andrew, Ben, and Tom discuss the DOJ investigation into Jay Powell, Trump's push to cap credit card interest rates, and Eli Lilly's consideration of acquiring Abivax.Join our live YouTube stream Monday through Friday at 8:30 AM EST:http://www.youtube.com/@TheMorningMarketBriefingPlease see disclosures:https://www.narwhal.com/disclosure

How American oil companies are responding following U.S. action in Venezuela? And why were Constellation investors happy with lower beer sales? Plus, how can a big pharma deal help Eli Lilly compete in a new treatment area? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them. Sign up for the WSJ's free Markets A.M. newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

How American oil companies are responding following U.S. action in Venezuela? And why were Constellation investors happy with lower beer sales? Plus, how can a big pharma deal help Eli Lilly compete in a new treatment area? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them. Sign up for the WSJ's free Markets A.M. newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

US equity futures point to a softer open, with Asian markets generally weaker and European equities narrowly mixed. Today's focus is on a pause in the recent pro-cyclical rally as geopolitical risks and upcoming event risk weigh on sentiment. Energy and financials underperformed amid renewed uncertainty around Venezuela developments, while Trump's social media comments on restricting institutional housing investment and curbing defense-sector buybacks added to sector-specific volatility. Moreover, macro data sent mixed signals, leaving Fed expectations broadly unchanged. Investors are now looking ahead to Friday's payrolls report, the pending Supreme Court ruling on Trump tariffs, and the next round of earnings and policy decisions as near-term catalysts.Companies Mentioned: Nvidia, Chevron, Eli Lilly, Ventyx Biosciences

Markets pulled back modestly Wednesday after reaching an intraday all-time high, as afternoon selling trimmed gains. While overall market trends remain constructive and prices are well above key moving averages, leadership is beginning to shift beneath the surface. Healthcare—one of the most oversold sectors back in September—has now rotated into the most overbought territory, with standout strength from names like Google and Eli Lilly. Meanwhile, traditionally defensive areas such as Staples, Utilities, and Real Estate are now among the most oversold sectors, suggesting potential opportunities if volatility picks up. Looking ahead, markets may face short-term catalysts from the Bloomberg Commodity Index rebalancing, which could introduce volatility within commodity-related assets. The first employment report of the new year arrives tomorrow, followed by the start of earnings season next week—both of which could move markets more meaningfully while volatility remains suppressed. Given elevated positioning and sensitivity to incoming data, we continue to advise caution with allocations as these key reports are released. Hosted by RIA Chief Investment Strategist, Lance Roberts, CIO Produced by Brent Clanton, Executive Producer --- Watch the Video version of this report on our YouTube channel: https://www.youtube.com/watch?v=l6zc2wXLn5o&list=PLwNgo56zE4RAbkqxgdj-8GOvjZTp9_Zlz&index=1 --- REGISTER for our 2026 Economic Summit, "The Future of Digital Assets, Artificial Intelligence, and Investing:" https://www.eventbrite.com/e/2026-ria-economic-summit-tickets-1765951641899?aff=oddtdtcreator --- Get more info & commentary: https://realinvestmentadvice.com/insights/real-investment-daily/ --- Visit our Site: https://www.realinvestmentadvice.com Contact Us: 1-855-RIA-PLAN --- Subscribe to SimpleVisor: https://www.simplevisor.com/register-new --- Connect with us on social: https://twitter.com/RealInvAdvice https://twitter.com/LanceRoberts https://www.facebook.com/RealInvestmentAdvice/ https://www.linkedin.com/in/realinvestmentadvice/ #MarketUpdate #SectorRotation #StockMarketNews #EconomicData #MarketVolatility

In der heutigen Folge sprechen die Finanzjournalisten Anja Ettel und Holger Zschäpitz über en Superzyklus bei Speicherchips, ein Double Downgrade bei Adidas und Comeback-Hoffnung bei Novo Nordisk. Außerdem geht es um Bitcoin, Ether, Western Digital, Seagate, Micron Technology, Samsung, Sandisk, SK Hynix, Nanya Technology, Nvidia, Johnson Controls, Trane Technologies, Carrier Global, Tesla, Eli Lilly, Ventyx Biosciences, Infineon, STMicroelectronics, Aixtron, SAP, Adidas, Nike, Asics, Puma, JD Sports, Novo Nordisk, Wisdom Tree Strategic Metals and Rare Earths Miners (WKN: A3EKKT), MP Materials, Lynas Rare Earths, Northam Platinum Holdings, Taseko Mines, Aurubis, VanEck Rare Earth and Strategic Metals (WKN: A3CRL9), PLS Group, Albemarle, China Northern Rare Earth, MP Materials, BNP Paribas Copper ETC (WKN: PB8C0P), Global X Copper Miners UCITS ETF (WKN: A3C7FZ), Sprott Pure Play Copper Miners (WKN: A3EWMH), Copper Miners ETF (WKN: A3ECC3), Freeport-McMoRan und Southern Copper. Wir freuen uns an Feedback über aaa@welt.de. Noch mehr "Alles auf Aktien" findet Ihr bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter. Hier bei WELT: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html. Der Börsen-Podcast Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte! https://linktr.ee/alles_auf_aktien Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Plus: Meta delays roll out of smartglasses to countries outside the U.S. amid high American demand. And a Bill Gates-backed nuclear fusion company has teamed up with Nvidia and Siemens. Julie Chang hosts. Learn more about your ad choices. Visit megaphone.fm/adchoices

Exosomes are becoming one of the most talked-about tools in regenerative medicine, but not all exosomes are created equal. In this episode of New Frontiers, Dr. Kara Fitzgerald talks with Alisa Lask, CEO of Plated Skin, about the science behind platelet-derived exosomes and why their signaling pathways matter for repair, renewal, and changes in skin appearance. We explore how discoveries in cardiology led to this technology, what early clinical studies are showing, and why source and preparation are critical when evaluating any exosome-based approach. A clear, grounded look at a fast-moving field for clinicians who want to understand what's real, what's emerging, and what deserves attention next. Full show notes + references: https://www.drkarafitzgerald.com/fxmed-podcast/ GUEST DETAILS Alisa Lask is the CEO of Rion Aesthetics, where she is driving innovation in regenerative aesthetics with platelet-derived exosomes and leading research in areas like hair restoration and skin appearance. She also oversees (plated)™ Skin Science, a medical-grade exosome skincare line distributed through aesthetic providers. Alisa previously held senior roles at Galderma, Allergan, Zimmer-Biomet, and Eli Lilly, and she serves on the Board of Directors for CollPlant. She holds an MBA from the University of Michigan and is also a nationally competitive show-jumping equestrian involved in dog rescue initiatives. THANKS TO OUR SPONSOR (plated)™ Skin Science: http://platedskinscience.com/ Plated Skin Science translates the discovery of Dr. Atta Behfar, M.D., Ph.D., Director of Mayo Clinic's Van Cleve Cardiac Regenerative Medicine Program into the first shelf-stable skincare line using regenerative, platelet-derived exosomes. These aren't generic exosomes; they're a specific class shown in peer-reviewed trials to regenerate skin's appearance by improving the look of wrinkles, pigmentation, luminosity, and overall skin quality. It's an elegant approach to visible signs of skin aging, recognized by Time as a Best Invention of 2024 and now used in more than 2,000 medical practices. Learn more at http://platedskinscience.com/ CONNECT with DrKF Want more? Join our newsletter here: https://www.drkarafitzgerald.com/newsletter/ Or take our pop quiz and test your BioAge! https://www.drkarafitzgerald.com/bioagequiz YouTube: https://tinyurl.com/hjpc8daz Instagram: https://www.instagram.com/drkarafitzgerald/ Facebook: https://www.facebook.com/DrKaraFitzgerald/ DrKF Clinic: Patient consults with DrKF physicians including Younger You Concierge: https://tinyurl.com/yx4fjhkb Younger You Practitioner Training Program: www.drkarafitzgerald.com/trainingyyi/ Younger You book: https://tinyurl.com/mr4d9tym Better Broths and Healing Tonics book: https://tinyurl.com/3644mrfw

Attorney General Todd Rokita is suing one of Indiana's largest companies, Eli Lilly and Co.,See omnystudio.com/listener for privacy information.

Indiana lawmakers gathered at the statehouse today for the second part of the session, following a contentious start in December over redistricting. Three weeks after announcing a “pause in operations,” Martin University's board of trustees announced in a letter published in the I Indianapolis Recorder that the college is closing its doors for good. Indiana Attorney General Todd Rokita is suing Indianapolis-based Eli Lilly and Company over the price of insulin. Indiana will not participate again in a federal program that helps families buy food for children during the summer. Indiana Colts Owner & CEO Carlie Irsay-Gordon holds a press conference on the team's season. The transfer portal is one of the big reasons Curt Cignetti was able to turn Indiana football into the top-ranked team in the country in just two years. Want to go deeper on the stories you hear on WFYI News Now? Visit wfyi.org/news and follow us on social media to get comprehensive analysis and local news daily. Subscribe to WFYI News Now wherever you get your podcasts. WFYI News Now is produced by Zach Bundy, with support from News Director Sarah Neal-Estes.

One on One Video Call W/George https://tidycal.com/georgepmonty/60-minute-meetingSupport the show:https://www.paypal.me/Truelifepodcast?locale.x=en_USTrueLife: Rites of Passage - Episode: The Cultivation of DependenceIn this eye-opening episode of TrueLife: Rites of Passage, host George Monty exposes the dark underbelly of modern dependency engineering—how corporations systematically turn free individuals into captive consumers through biological, psychological, and economic addictions. From pharmaceuticals that hook you for life to hyper-palatable foods and addictive apps, Monty reveals how “customer lifetime value” is just code for human farming, where independence is eroded for perpetual profit.  Monty dives deep into real-world examples: Purdue Pharma's deliberate strategies to create dependence with OxyContin, as uncovered in internal documents  ; Eli Lilly's knowledge of Prozac's permanent neurochemical changes and severe discontinuation syndrome since 1984  ; and the infamous 2018 Goldman Sachs report questioning if “curing patients” is a sustainable business model, favoring chronic treatments instead.   He also uncovers the DSM-5's expansion of mental disorders in 2010, influenced by pharmaceutical ties  ; AstraZeneca's proton pump inhibitors creating “annuity patients” through long-term use  ; and Meta's (Facebook's) 2021 leaked memo admitting Instagram worsens body image issues for 32% of teen girls to keep users hooked.  Beyond drugs, Monty explores food engineering at Frito-Lay, where flavors are lab-designed to mimic cocaine-like dopamine hits  ; Meta's 2017 internal tactics using variable rewards to ensure users return compulsively ; and the shift to subscription models in software and finance that make opting out impossible.This episode challenges listeners to audit their dependencies—medications, apps, subscriptions—and reclaim autonomy. End with a call to action: Research your “needs,” break the hooks, and become unfarmable. Tune in for tomorrow's unmasking of automated compliance.https://www.cnbc.com/2018/04/11/goldman-asks-is-curing-patients-a-sustainable-business-model.htmlhttps://arstechnica.com/tech-policy/2018/04/curing-disease-not-a-sustainable-business-model-goldman-sachs-analysts-say/https://www.statnews.com/2019/12/03/oxycontin-history-told-through-purdue-pharma-documents/https://pmc.ncbi.nlm.nih.gov/articles/PMC2622774/https://www.wisnerbaum.com/advocacy_campaigns/ssri-documents/https://www.scribd.com/document/413333146/Eli-Lilly-Prozac-Documents-What-Do-They-Revealhttps://arstechnica.com/tech-policy/2018/04/curing-disease-not-a-sustainable-business-model-goldman-sachs-analysts-say/https://www.aaup.org/academe/issues/2010-issues-4/diagnosing-conflict-interest-disorderhttps://pmc.ncbi.nlm.nih.gov/articles/PMC3302834/https://www.bradleygrombacher.com/nexium-proton-pump-inhibitor-lawsuit-claims-severe-patient-injurieshttps://www.astrazeneca.com/content/astraz/media-centre/press-releases/2023/astrazeneca-settles-nexium-and-prilosec-product-liability-litigations.htmlhttps://www.theguardian.com/technology/2021/sep/14/facebook-aware-instagram-harmful-effect-teenage-girls-leak-revealshttps://topclassactions.com/lawsuit-settlements/lawsuit-news/frito-lay-sued-over-no-artificial-flavors-claim-on-poppables-snacks/https://www.bakeryandsnacks.com/Article/2025/10/07/pepsico-sued-over-mold-made-citric-acid-in-poppables/ One on One Video call W/George https://tidycal.com/georgepmonty/60-minute-meetingSupport the show:https://www.paypal.me/Truelifepodcast?locale.x=en_US

Looking at a weird GDP data point. Calling BS on Russia/Ukraine peace talks. Gold and Silver – WOW! Closing out the year – a good one too! PLUS we are now on Spotify and Amazon Music/Podcasts! Click HERE for Show Notes and Links DHUnplugged is now streaming live - with listener chat. Click on link on the right sidebar. Love the Show? Then how about a Donation? Follow John C. Dvorak on Twitter Follow Andrew Horowitz on Twitter Warm-Up - CTP Cup - All systems go! 9 participants! - Lots to be excited about and anxious too - Looking at a weird GDP data point - Calling BS on Russia/Ukraine peace talks Markets - Gold and Silver - WOW! - Closing out the year - a good one too! - Buyers are still hot to buy any dip - "Diet" pills coming Bitters Making Progress  - Chocolate -Dark Cherry -Infusions - https://highdesertbotanicals.com NYE Celebration - Cities across America ring in the new year by dropping unexpected objects: - Amelia Island, FL drops a giant shrimp. - Nashville drops a 400lb musical note with 28,140 LEDs. - Boise, ID, drops a glowing potato. - Key West, FL, drops an eight-foot ruby-red heel—complete with a drag queen inside! - In Spain, revelers gulp down 12 grapes—one for each midnight chime—to bring luck for each month - Denmark - Danes toss old dishes at friends' doors—large piles of broken crockery at dawn are seen as tokens of good luck. What a year! - So many themes in 12 months - AI, Tariffs, War and Trade War, Fat drugs, Deglobalization - Data centers, semiconductors, and supporting infrastructure like power and cooling systems. - Approx: DJIA +13.5%, SP500 +17%, NASDA +21%, BTCUSD -7.6%, Gold +64%, SLV +145%, $DXY -9.5%, EEM +30% - 2026 - Opportunities and Auld Lang Xiety (Tech still looks frothy in certain names) Top New Year's Resolutions - Exercise More - Eat Healthier - Save More Money/Get Out of Debt - Be Happy/Improve Mental Health - Lose Weight - Spend More Time with Family & Friends - Learn a New Skill/Hobby - Get Organized Active Management (Funds) - Same report annually - A small group of tech super stocks accounted for an outsize share of returns in 2025, extending a pattern in place for the better part of a decade. - Around $1 trillion was pulled from active equity mutual funds over the year, marking an 11th year of net outflows, while passive equity exchange-traded funds got more than $600 billion. - The concentration of gains in a few stocks made it harder for active managers to do well, with 73% of equity mutual funds trailing their benchmarks this year, the fourth most in data going back to 2007. - BUT, there are some areas that it makes sense for active management ---- Equity vs Fixed income and reasoning --- Efficient markets, boots on the ground Fat Pill - The FDA has approved the first-ever GLP-1 pill from Wegovy maker Novo Nordisk. - Novo Nordisk said the starting dose of 1.5 milligrams will be available in early January in pharmacies and via select telehealth providers with savings offers for $149 per month. - The approval gives Novo Nordisk a head start over chief rival Eli Lilly, which is racing to launch its own obesity pill. - Packaged food makers and fast-food restaurants may be forced to overhaul more of their products next year as newly approved, appetite-suppressing GLP-1 pills become available in January PowerBall - A ticket sold in Arkansas scored a $1.8 billion Powerball jackpot after Wednesday night's draw — one of the richest lottery prizes in U.S. history, landing just in time for Christmas. - The payout soared after last Monday's drawing produced no winners, with last-minute ticket sales pushing the jackpot to $1.817 billion. That makes it the second-largest U.S. lottery prize ever and the biggest Powerball of 2025, the lottery website said on Thursday. - The winning numbers — 4, 25, 31, 52, 59 and the Powerball 19 - Odds: one in 292.2 million. Silver - Amazing year! - Sunday night futures - >$83 then turned hard lower| - Down 7% on Monday - Range $83 - $71 (15%) for the day - Some rumors about a bank collapse due to wrong way position on Silver - forced liquidation and covering.... ----- Hard to believe that a bank was short that much silver - but..... SoKo Breach - South Korean online retail giant Coupang said it will offer 1.69 trillion South Korean won ($1.17 billion) in compensation to 34 million users affected by a massive data breach disclosed last month. - That is about 4% of Coupang's annual revenue - but a big chunk of their profit - $34 per user NVDA Deal - Nvidia has yet to issue a public announcement or disclosure regarding its $20 billion Groq deal that CNBC was first to cover on Wednesday. - Groq described the deal as a “non-exclusive licensing agreement,” a tool that's been used by tech giants of late in part to avoid regulatory scrutiny. - Analyst: “Antitrust would seem to be the primary risk here, though structuring the deal as a non-exclusive license may keep the fiction of competition alive,” Bernstein's Stacy Rasgon wrote in a report. - Groq will remain an independent company (?) GDP Consumption - Something is a bit off.... - With the marketplace costs increasing, this may be more than a one-off expenditure Q3 GDP Surge Russia/Ukraine - Less that an hour after the White House claimed great movement toward peace - Russian President Putin told President Trump that Russia will revise its negotiating position, raising questions over prospects for peace deal - Russian Foreign Minister Sergei Lavrov says Ukraine tried to attack Russian President Putin's residence - Does anyone even listen to the crap coming out of the White House anymore? - Did you hear Lutnick trying to explain the 600% reduction in costs for pharmaceuticals? Math wizards! - - For 2026, my wish is that they continue to work on the job at hand and just shut up Just for fun - Who is biggest drinker of spirits? - While there's no single official "heaviest drinker," legendary wrestler Andre the Giant is widely cited as having unmatched capacity, famously downing 119 beers in one sitting (or even up to 156 in other accounts) Oil - Crude oil futures down about 9.5% YTD - Much of the drop due to pick up in production (supply/demand) - Still a floor with as Russia, Nigeria, Venezuela etc - What will it take to move up? Best Auto Stock for 2025? - GM! Better than ford, Tesla and others (up 55%) - best year from coming out of bankruptcy in 2009 - Ford up 35% - Mary Barra, CEO selling into the strength - $73 M sold this year (Position down 73% from what she held last year) - - - Barra has contended for years that stock undervalued. With all of these say what does that say now? --- Would she ever say shares are overvalued? More fun stats - A peer?reviewed 2025 study estimates AI data centers (including indirect usage from electricity generation) consumed 312–765 billion liters of water annually. That's more than all bottled water consumed worldwide each year - Direct (on-site) water is used for cooling servers via systems like cooling towers or liquid loops. Indirect (off-site) water stems from electricity generation—particularly from thermal and nuclear plants, which require significant cooling resources - ??? Estimates suggest a single standard AI prompt (about 100 words) is linked to around 1.5 liters of water—accounting for the entire chain of consumption. (This is total usage from cooling powr consumption, electricity generation) - Global AI workloads consumed 50–60 terawatt-hours (TWh) in 2025—roughly the annual electricity use of a medium-sized country like Switzerland. - By 2030, AI-related electricity demand could reach 300–500 TWh annually, according to energy analysts—comparable to the entire electricity consumption of countries like France. Over to Iran - President Trump tells reporters that if Iran is building up its nuclear program, the U.S. will have to "knock them down" again --- Wait - I thought we destroyed all of their nuke aspirations??? - - - AND - Iran's currency hit a record low, triggering wave of protests, according to Bloomberg Fed News - Top Fed Chair Candidate Odds Narrow Again, With Hassett at 43% and Warsh at 35% - President Trump still angry at Powell 0threating to sue for incompetence Odd - Tesla Inc. published a series of sales estimates indicating the outlook for its vehicle deliveries may be lower than many investors were expecting. - The carmaker posted estimates showing analysts on average expect the company to deliver 422,850 cars in the fourth quarter, down 15% from a year earlier. - Tesla is on course for its second consecutive drop in annual vehicle sales, with the company compiling an average estimate for 1.6 million deliveries, down more than 8% from a year earlier. - These are estimates published by analysts - Tesla put on its own site - WHY? End of Year Stat - The U.S. national debt is climbing at a rapid pace and has shown no signs of slowing down despite the growing criticism of massive levels of government spending. - The national debt, which measures what the U.S. owes its creditors, rose to $38,386,384,190,622.68 as of Dec. 30, according to the latest numbers published by the Treasury Department. - That is an increase of about $5.8 billion daily - ~$18 per person in the US per day increase ($7,300) - or about the monthly price of leasing a small Mercedes - Each person in US owes approx $128,000 Love the Show? Then how about a Donation? THE CLOSEST TO THE PIN 2025 Winners will be getting great stuff like the new "OFFICIAL" DHUnplugged Shirt! CTP CUP 2025 Participants: Jim Beaver Mike Kazmierczak Joe Metzger Ken Degel David Martin Dean Wormell Neil Larion Mary Lou Schwarzer Eric Harvey (2024 Winner) FED AND CRYPTO LIMERICKS See this week's stock picks HERE Follow John C. Dvorak on Twitter Follow Andrew Horowitz on Twitter

In this episode, we get an update on Anti-Amyloid therapies and ARIA, along with the new POC tool to help physicians navigate these therapeutics and how they may impact patients in the emergency department. We talk with Dr. Christina Shenvi who introduced us to ARIA earlier in the year and now we have more evidence and a POC tool. Supported by Eli Lilly, USA

Justin Nielsen and Alexis Garcia analyze Monday's market action and discuss key stocks to watch in Stock Market Today. Learn more about your ad choices. Visit megaphone.fm/adchoices

GLP-1 drugs have become one of the most important developments in the pharmaceutical industry. With products like Ozempic, Wegovy, and Mounjaro in high demand, competition between drug makers is growing quickly. In this episode of Down to Business English, Skip Montreux and Dez Morgan get Down to Business with GLP-1 inhibitors — the drugs behind today's weight-loss boom. They explain who the main players are, including Novo Nordisk and Eli Lilly, and compare their leading products. Their discussion also looks at a major recent development: Pfizer's acquisition of biopharma startup Metsera, and why this deal could significantly change the market. Skip and Dez's conversation gives listeners a clear and practical introduction to competition and strategy in the pharmaceutical industry — while helping you improve your Business English. In this episode, you will learn: What GLP-1 drugs are and what they are used for. The main differences between Ozempic, Wegovy, Mounjaro, and Zepbound. Why Eli Lilly is gaining market share, especially in North America. How Pfizer's acquisition could affect future weight-loss treatments. Do you like what you hear? Become a D2B Member today for to access to our -- NEW!!!-- interactive audio scripts, PDF Audio Script Library, Bonus Vocabulary episodes, and D2B Member-only episodes. Visit d2benglish.com/membership for more information. Follow Down to Business English on Apple podcasts, rate the show, and leave a comment. Contact Skip, Dez, and Samantha at downtobusinessenglish@gmail.com Follow Skip & Dez Skip Montreux on Linkedin Skip Montreux on Instagram Skip Montreux on Twitter Skip Montreux on Facebook Dez Morgan on Twitter RSS Feed

Broadcast from KSQD, Santa Cruz on 12-18-2025: Dr. Dawn opens by examining how market competition is actually working in the weight loss drug sector. Novo Nordisk's Ozempic and Wegovy compete against Eli Lilly's Monjaro and ZepBound, with prices dropping nearly 50% as companies launch direct-to-consumer websites. The main barriers remain needles and refrigeration, driving development of oral versions. Novo's Wegovy pill awaits FDA approval for early 2026 launch at $150 monthly. Next-generation drugs show remarkable results: Eli's retatrutide causes 24% weight loss in 48 weeks, while Novo's Cagrisema combines semaglutide with amylin to reduce muscle loss. Pfizer paid $10 billion for Metsera's once-monthly drug despite significant side effects. A quick fiber tip suggests adding plain psyllium to morning coffee for cardiovascular and microbiome benefits. Start with half a teaspoon and work up to two teaspoons (10 grams) over several weeks to avoid gas. The prebiotic fiber improves glucose tolerance and may reduce cancer risk. UC San Diego scientists discovered why cancers mutate so rapidly despite being eukaryotic cells with protected chromosomes. The answer is chromothripsis, a catastrophic event where the enzyme N4BP2 literally explodes chromosomes into fragments. These reassemble incorrectly, generating dozens to hundreds of mutations simultaneously and creating circular DNA fragments carrying cancer-promoting genes. One in four cancers show evidence of this mechanism, with all osteosarcomas and many brain cancers displaying it. This explains why the most aggressive cancers resist treatment. Research from 2013 shows any glucocorticoid use significantly increases venous thromboembolism risk, with threefold increases during the first month of use. The risk applies to new and recurrent clots, affecting both oral and inhaled steroids, though IV poses highest risk and topical the lowest. Joint injections fall somewhere between inhaled and oral. Anyone with prior blood clots should avoid steroids except for life-threatening situations like severe asthma attacks requiring ventilation. A meta-analysis of 20 randomized controlled trials shows creatine supplementation helps older adults (48-84) maintain muscle mass when combined with weight training two to three times weekly. The supplement provides no benefit without exercise. Recommended dosing starts at 2 grams and works up to 5 grams daily. Vegans benefit most since they consume little meat or fish. Important caveat: creatine throws off standard kidney function tests (creatinine), so users should request cystatin C testing instead for accurate renal health assessment. A new JAMA study suggesting risk-based mammogram screening is fatally flawed. First, researchers offered chemopreventative drugs like tamoxifen only to the high-risk group, contaminating the study design. Second, the demographics skewed heavily toward white college-educated women, missing the reality that Black women face twice the risk of aggressive breast cancer with 40% higher mortality. Third, wild-type humans failed to follow instructions—low-risk women continued getting annual mammograms anyway while high-risk women skipped recommended extra screenings. The conclusion of "non-inferior" outcomes is meaningless given poor adherence. Stick with annual mammograms, and consider alternating with MRIs for high-risk women. The EAT-Lancet report condemns red meat based purely on observational data showing correlations with heart disease, cancer, and mortality. But people who eat lots of red meat differ dramatically from low consumers: they weigh more, smoke more, exercise less, and eat less fiber. Studies can't control for sleep quality, depression, or screen time. Notably, heavy meat eaters also die more in accidents, suggesting a risk-taking lifestyle phenotype. The inflammatory marker TMAO is higher in meat eaters, but starch is also pro-inflammatory. Eating red meat instead of instant ramen might improve health. A balanced diet with limited amounts beats epidemiology-based blanket statements. Dr. Dawn grades Dr. Oz's performance as CMS administrator. Starting at minus one for zero relevant experience, he earns plus two for promoting diet, exercise, and gut health on his show. He studied intensively after nomination, calling all four previous CMS directors repeatedly and surrounding himself with experienced staff (plus one). He finalized Medicare rules favoring prevention over surgery and earned bipartisan praise as "a real scientist, not radical" (plus one). He divested healthcare holdings but kept some blind trust interests (minus 0.5). He's developing a CMS app and partnering with Google on a digital health ecosystem (plus one), but supports ending ACA subsidies that will raise premiums for millions (minus one). He correctly promoted COVID vaccines and contradicted Trump's Tylenol-autism claims (plus one). Final score: 3.5 out of 5 possible points, the only positive score for any Trump health administrator.

Tom Sego, founder and CEO of BlastWave, discussed his background in chemical engineering and his journey through various industries, including roles at Caterpillar, Eli Lilly, Emerson Electric, Alta Vista, and Apple. He explained that BlastWave was founded to combine Apple’s ease of use with cybersecurity, focusing on protecting critical infrastructure as it becomes increasingly digitized. Tom emphasized that human error is a significant security risk, citing an example from the San Jacinto Water District. This Follower Friday podcast is sponsored by UTSI International. Tom's podcast includes: Critical infrastructure sectors (like oil and gas, transportation, and manufacturing) face higher cyber risks than traditional IT systems due to the severe consequences of attacks and the challenge of securing legacy devices. Integrating old and new technologies is achieved by using a translation mechanism that enables secure communication between legacy systems and modern infrastructure. Artificial intelligence (AI) has a dual impact: it can enhance attackers' ability to automate cyberattacks, but it also offers opportunities to improve security, such as by eliminating vulnerabilities like passwords. Technology solutions are essential for reducing the human burden in security, especially for defending against phishing and reconnaissance attacks. Eliminating attack vectors (e.g., usernames and passwords) can significantly reduce security risks, regardless of how effective or frequent attacks become. Focusing on the safety of critical infrastructure allows people to prioritize what matters most in life, such as family, relationships, and health. To be an Insider Please subscribe to The Green Insider powered by ERENEWABLE wherever you get your podcast from and remember to leave us a five-star rating. This podcast is sponsored by UTSI International. To learn more about our sponsor or ask about being a sponsor, contact ERENEWABLE and the Green Insider Podcast. The post Securing Critical Infrastructure: Insights from Tom Sego appeared first on eRENEWABLE.

Recent data shows the UK economy shrinking and German industrial production stalling, while US PMI data remains robust. This divergence suggests the US remains the "cleanest dirty shirt" in the global economy.Today's Stocks & Topics: First Trust Water ETF (FIW), Market Wrap, Residential Real Estate in the Bay Area, “Global Divergence: Europe Stalls, US Chugs Along”, Contango Ore, Inc. (CTGO), Dolly Varden Silver Corporation (DVS), Options & Capital Gains, Transport Stocks, NFLX and WBD Merge, Costco Wholesale Corporation (COST), Eli Lilly and Company (LLY), Bank Stocks.Our Sponsors:* Check out ClickUp and use my code INVEST for a great deal: https://www.clickup.com* Check out Incogni: https://incogni.com/investtalk* Check out Invest529: https://www.invest529.com* Check out NordProtect: https://nordprotect.com/investalk* Check out Progressive: https://www.progressive.com* Check out Quince: https://quince.com/INVEST* Check out TruDiagnostic and use my code INVEST for a great deal: https://www.trudiagnostic.comAdvertising Inquiries: https://redcircle.com/brands

In this episode of the IoT For All Podcast, Barry Libert, Chairman and CEO of HiveMQ, joins Ryan Chacon to discuss moving past the pilot phase in industrial IoT and AI. The conversation covers viewing businesses as data streaming entities, the importance of understanding one's data collection processes, aligning different tiers of employees to achieve success, the shift from connectivity to AI data platforms, the role of agentic workflows, and the type of leadership required to navigate the evolving landscape of data and AI.Barry Libert is the Chairman and CEO of HiveMQ. He has spent 40+ years as a board member, CEO, and serial entrepreneur. He founded and exited several businesses, advised more than 350 CEOs, and served on more than 35 boards in his career. Most recently, Barry transformed Anaconda into a unicorn, adding $100M in new ARR in 18 months based on a proprietary open- source/open-core commercialization GTM playbook he co-designed and implemented.Barry is focused on AI platforms with network effects and data moats. He has co-authored 6 books, 20+ ebooks, and 500+ articles in the WSJ, NYT, HBR, MIT, and Forbes. He has appeared on CNN, CNBC, Fox, NPR, and delivered 500+ speeches to 250,000+ people globally. Barry began his career with McKinsey & Company, was a managing director of John Hancock's $2B Real Estate Equity arm, and was a partner at Arthur Andersen. Barry is a graduate of Tufts University (BA) and Columbia University (MBA).HiveMQ is the Industrial AI Platform helping enterprises move from connected devices to intelligent operations. Built on the MQTT standard and a distributed edge-to-cloud architecture, HiveMQ connects and governs industrial data in real time, enabling organizations to act with intelligence. With proven reliability, scalability, and interoperability, HiveMQ provides the foundation industrial companies need to operationalize AI, powering the next generation of intelligent industry. Global leaders including Audi, BMW, Eli Lilly, Liberty Global, Mercedes-Benz, and Siemens trust HiveMQ to run their most mission-critical operations.Discover more about IoT and AI at https://www.iotforall.comFind IoT solutions: https://marketplace.iotforall.comMore about HiveMQ: https://www.hivemq.comConnect with Barry: https://www.linkedin.com/in/barrylibert/Subscribe on YouTube: https://bit.ly/2NlcEwmJoin Our Newsletter: https://newsletter.iotforall.comFollow Us on Social: https://linktr.ee/iot4all

Plus, Eli Lilly reports dramatic weight loss in a clinical trial of a next-generation obesity drug. And the U.S. trade deficit fell to a five-year low in September. Pierre Bienaimé hosts. Sign up for WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

The price of Warner Brothers Discovery could creep higher as both Paramount and Netflix ready to up their offers in a possible bidding war, computer memory maker and Nvidia supplier SK hynix is considering listing shares in the U.S., Disney is nominating former Apple executive Jeff Williams to join its board, Eli Lilly will spend $6 billion to build a manufacturing plant in Alabama, and European company Delivery Hero says its evaluating its strategic options after a stock slump. Squawk Box is hosted by Joe Kernen, Becky Quick and Andrew Ross Sorkin.  Follow Squawk Pod for the best moments, interviews and analysis from our TV show in an audio-first format. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Novo Nordisk can't keep up with demand for Ozempic and Wegovy, giving competitor Eli Lilly the edge in the GLP-1 market. And off-brand competitors continue to hammer the company's market position. Layoffs and board resignations signal that Novo Nordisk has entered a downward spiral. But with new leaders, acquisitions and deals, can they force a comeback?See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Kara and Scott discuss X's new “About This Account” feature, which appears to show a wave of MAGA accounts posting from Russia, India, Nigeria, and beyond. They also unpack Marco Rubio denying reports that he privately called the Ukraine peace plan a Russian “wish list.” Plus, Google scores a major win with Gemini 3, Eli Lilly hits $1 trillion in market cap, and Marjorie Taylor Greene announces her exit from Congress. Watch this episode on the ⁠⁠Pivot YouTube channel⁠⁠.Follow us on Instagram and Threads at ⁠⁠@pivotpodcastofficial⁠⁠.Follow us on Bluesky at ⁠⁠@pivotpod.bsky.social⁠⁠Follow us on TikTok at ⁠⁠@pivotpodcast⁠⁠.Send us your questions by calling us at 855-51-PIVOT, or email Pivot@voxmedia.com Learn more about your ad choices. Visit podcastchoices.com/adchoices

Three more suspects, including two affluent New Jersey teens, are now charged in a foiled ISIS-inspired Halloween terror plot, bringing the total to five. The FAA is cutting up to 10% of flights at 40 major airports as the government shutdown enters week six, triggering nationwide delays. President Trump announces a deal with Eli Lilly and Novo Nordisk to slash the cost of popular GLP-1 weight-loss drugs like Wegovy and Ozempic to about $350 through a new program called TrumpRX. Former House Speaker Nancy Pelosi, 85, announces she will not seek reelection after nearly four decades in Congress and two impeachments of President Trump. Geviti: Go to https://gogeviti.com/megynand get 20% off with code MEGYN. Walmart: Learn how Walmart is fueling the future of U.S. manufacturing at https://Walmart.com/America-at-work Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.